MedPath

Role of Sweetness in Glucose Regulation

Not Applicable
Conditions
Obesity
Interventions
Other: Control - Inhibition
Other: Control- Stimulation
Other: Experimental I- Inhibition
Other: Experimental I- Stimulation
Other: Experimental II- Inhibition
Other: Experimental II- Stimulation
Other: Sensory Evaluation
Registration Number
NCT03844230
Lead Sponsor
University of Illinois at Urbana-Champaign
Brief Summary

Data from several studies show that consuming a diet high in low-calorie sweeteners (LCS), mainly in diet sodas, is linked to the same metabolic disorders as consuming a diet high in added sugars, including an increased risk of developing type 2 diabetes. Sweet taste receptors, once thought to be unique to the mouth, have now been discovered in other parts of the body, including the intestine and the pancreas, where they play a role in blood sugar control. These newly identified receptors provide new avenues to explore how LCS may affect metabolism and health. This project is designed to examine the role of sweet taste signaling, both in the mouth and in the gut, on blood sugar control and how habitual consumption of LCS may affect sweet taste signaling and metabolism in people with obesity.

Detailed Description

The overall goal of this research is to assess the role of oral and gut sweetness signaling in postprandial glucose metabolism and to determine how acute and chronic low-calorie sweetener (LCS) consumption may affect this signaling in people with obesity. The aims will determine the independent and combined contributions of pharmacological inhibition (Aim 1) or extra stimulation (Aim 2) of sweet taste signaling in the gut, mouth, or both on hormonal responses to an oral glucose tolerance test (OGTT) in two groups of subjects with obesity: habitual and non-habitual LCS consumers. Validated sensory evaluation techniques will also ascertain subjects' taste perception (Aim 3) to test the hypotheses that habitual consumption of LCS blunts perception of sweetness and, in turn, affects postprandial glucose regulation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • All races/ethnicities
  • Habitual (> 5 diet sodas per week) and non-habitual (≤1 diet soda or 1 packet of LCS per week) LCS consumers
  • 30 ≤ BMI <40 kg/m2
  • Not severely insulin resistant (HOMA-IR2 < 2.6)
Exclusion Criteria
  • BMI < 30 and 40< BMI kg/m2
  • HOMA-IR2>2.6
  • Irregular LCS consumers (>1 diet sodas or packets of LCS per week but <5)
  • Current smokers or quit smoking nicotine cigarettes for less than 6 months ago
  • Pregnant, breastfeeding, menopausal
  • Presence of anemia : <12g/dl for women and <13g/dl for men
  • Blood donation in the past 8 weeks
  • Presence of malabsorption syndrome
  • History of bariatric surgery
  • Presence of inflammatory intestinal disease, liver or kidney disease
  • Have diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucose challenge >200 mg/dl)
  • Taking any medication that might affect glucose metabolism or the results of our study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Inhibition GroupExperimental I- InhibitionRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Inhibition GroupExperimental II- InhibitionRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Inhibition GroupSensory EvaluationRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Stimulation GroupExperimental II- StimulationRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Stimulation GroupSensory EvaluationRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Inhibition GroupControl - InhibitionRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Stimulation GroupControl- StimulationRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Stimulation GroupExperimental I- StimulationRandomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Primary Outcome Measures
NameTimeMethod
Sensory EvaluationUp to 2 hours

Participants will be tasting solutions containing different concentrations of glucose, sucrose and sucralose (some of the solutions will also have lactisole) to assess their detection threshold, sweet taste intensity and preference. They will have to rate the intensity of the solution on a general Labeled Magnitude Scale (gLMS) ranging from "no sensation" (0) to "strongest imaginable sensation" (100) and choose the solutions they prefer.

Plasma GlucoseUp to 5 hours after drinking a glucose load

Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma glucose concentration

Plasma InsulinUp to 5 hours after drinking a glucose load

Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma insulin concentration

Plasma C-PeptideUp to 5 hours after drinking a glucose load

Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma C-peptide concentration

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois at Urbana Champaign

🇺🇸

Champaign, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath